wy 41770 has been researched along with Adjuvant Arthritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlson, RP; Chang, J; Datko, LJ; Lewis, AJ; Nielsen, ST | 1 |
Carlson, RP; Datko, LJ; Lewis, AJ; O'Neill-Davis, L | 1 |
2 other study(ies) available for wy 41770 and Adjuvant Arthritis
Article | Year |
---|---|
The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Carrageenan; Cyclooxygenase Inhibitors; Dibenzocycloheptenes; Digestive System; Dinoprostone; Edema; Fever; Hyperesthesia; In Vitro Techniques; Irritants; Lipoxygenase Inhibitors; Macrophages; Male; Platelet Aggregation; Pleurisy; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Seminal Vesicles; Synovitis; Yeast, Dried | 1984 |
Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid.
Topics: Acetates; Animals; Arthritis, Experimental; Dibenzocycloheptenes; Encephalomyelitis, Autoimmune, Experimental; Erythrocytes; Guinea Pigs; Hypersensitivity, Delayed; Immune System; Immunoglobulin M; Indomethacin; Levamisole; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Lew | 1986 |